Analysis results revealed that two-hit EIII-SNPs plus anti-CD41 treatments indeed induced exacerbated thrombocytopenia in mice when compared to the other control groups (Figure 2A, experiment outline; Figure 2B, mouse platelet counts). The gene discussed is ITGA2B; the disease is Thrombocytopenia.